By Jamie Lennox ( August 20, 2025, 2:02 PM BST) -- A pharmaceuticals company has asked a London court to confirm that its blood pressure drug does not infringe a competitor's patent as it seeks to clear a path to carry on selling the treatment in the U.K....

See Full Page